Prestilol(Perindopril+Bisoprolol) in Therapy of Patients With Atrial Fibrilation

Perindopril+Bisoprolol in Therapy of Patients With Atrial Fibrilation

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04484688

Enrollment

Registered

2020-07-23

Start date

2020-08-01

Completion date

2021-12-01

Last updated

2020-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient Participation

Brief summary

The study aims to evaluate the effectiveness and safety of oral fixed-dose combination of bisoprolol/perindopril in patients with permanent atrial fibrillation

Interventions

DRUGperindopril-bisoprolol

outpatients with permanent atrial fibrillation and with preserved ejection fraction

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

permanent atrial fibrillation with normal EF -

Exclusion criteria

AF with decreased EF \-

Design outcomes

Primary

Measure	Time frame
12-ecg and echocardiography evaluation after 1 month treatment	1 month

Countries

Georgia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026